Continue reading After 6 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss No significant change to the risk of telogen effluvium No significant change to the risk of alopecia areata After 12 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss Increased risk of telogen effluvium No significant change to the risk of alopecia areata Interestingly, no increased risk of alopecia areata was found, given that GLP-1 medications like semaglutide have been reported to be linked to this condition in case studies
If your protocol specifies doses per compound (e.g., 0.5mg Tesamorelin + 0.5mg Ipamorelin), add them to get total dose (1mg), then divide by concentration to get injection volume
Gila monsters' venom has a compound in it that can regulate hunger
In Study 7, the proportions of patients who discontinued study drug were 18% and 25.5% for WEGOVY 25 mg tablet and placebo, respectively
Sleep regulation: DSIP has been shown to promote slow-wave (delta) sleep, the deepest and most restorative stage of the sleep cycle
Core Peptides (corepeptides.com) is a US-based research peptide vendor that has been operating for approximately 3-4 years
